Literature DB >> 25555397

Further understanding of tau phosphorylation: implications for therapy.

Miguel Medina1, Jesús Avila.   

Abstract

Tau is a brain microtubule-associated protein that regulates microtubule structure and function. Prominent tau neurofibrillary pathology is a common feature in a number of neurodegenerative disorders collectively referred to as tauopathies, the most common of which is Alzheimer's disease. Beyond its classical role as a microtubule-associated protein, recent advances in our understanding of tau cellular functions have unveiled novel important tau cellular functions that may also play a pivotal role in pathogenesis and render novel targets for therapeutic intervention. Regulation of tau behavior and function under physiological and pathological conditions is mainly achieved through post-translational modifications, especially phosphorylation, which has significant implications for the development of novel therapeutic approaches in a number of neurodegenerative disorders.

Entities:  

Keywords:  Alzheimer; aggregation; dementia; kinases; memory; neurodegeneration; neurofibrillary tangles; phosphorylation; tau; tauopathies

Mesh:

Substances:

Year:  2015        PMID: 25555397     DOI: 10.1586/14737175.2015.1000864

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  17 in total

1.  Lamin Dysfunction Mediates Neurodegeneration in Tauopathies.

Authors:  Bess Frost; Farah H Bardai; Mel B Feany
Journal:  Curr Biol       Date:  2015-12-24       Impact factor: 10.834

2.  Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT-deleted (DM) tau mouse model.

Authors:  Jeremy Koppel; Heidy Jimenez; Leslie Adrien; Eric H Chang; Anil K Malhotra; Peter Davies
Journal:  J Neurochem       Date:  2018-11-12       Impact factor: 5.372

3.  Synergistic effects of particulate matter (PM2.5) and sulfur dioxide (SO2) on neurodegeneration via the microRNA-mediated regulation of tau phosphorylation.

Authors:  Tingting Ku; Minjun Chen; Ben Li; Yang Yun; Guangke Li; Nan Sang
Journal:  Toxicol Res (Camb)       Date:  2016-11-09       Impact factor: 3.524

4.  A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.

Authors:  Nicolas R Barthélemy; Yan Li; Nelly Joseph-Mathurin; Brian A Gordon; Jason Hassenstab; Tammie L S Benzinger; Virginia Buckles; Anne M Fagan; Richard J Perrin; Alison M Goate; John C Morris; Celeste M Karch; Chengjie Xiong; Ricardo Allegri; Patricio Chrem Mendez; Sarah B Berman; Takeshi Ikeuchi; Hiroshi Mori; Hiroyuki Shimada; Mikio Shoji; Kazushi Suzuki; James Noble; Martin Farlow; Jasmeer Chhatwal; Neill R Graff-Radford; Stephen Salloway; Peter R Schofield; Colin L Masters; Ralph N Martins; Antoinette O'Connor; Nick C Fox; Johannes Levin; Mathias Jucker; Audrey Gabelle; Sylvain Lehmann; Chihiro Sato; Randall J Bateman; Eric McDade
Journal:  Nat Med       Date:  2020-03-11       Impact factor: 53.440

Review 5.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

Review 6.  New Features about Tau Function and Dysfunction.

Authors:  Miguel Medina; Félix Hernández; Jesús Avila
Journal:  Biomolecules       Date:  2016-04-19

7.  Deciphering the Interplay among Multisite Phosphorylation, Interaction Dynamics, and Conformational Transitions in a Tripartite Protein System.

Authors:  Philip Lössl; Andrea M Brunner; Fan Liu; Aneika C Leney; Masami Yamashita; Richard A Scheltema; Albert J R Heck
Journal:  ACS Cent Sci       Date:  2016-06-10       Impact factor: 14.553

8.  Effects of microtubule-associated protein tau expression on neural stem cell migration after spinal cord injury.

Authors:  Zhi-Ping Qi; Guo-Xiang Wang; Peng Xia; Ting-Ting Hou; Hong-Li Zhou; Tie-Jun Wang; Xiao-Yu Yang
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

Review 9.  Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease.

Authors:  Francesco Panza; Vincenzo Solfrizzi; Davide Seripa; Bruno P Imbimbo; Madia Lozupone; Andrea Santamato; Chiara Zecca; Maria Rosaria Barulli; Antonello Bellomo; Alberto Pilotto; Antonio Daniele; Antonio Greco; Giancarlo Logroscino
Journal:  Biomed Res Int       Date:  2016-06-26       Impact factor: 3.411

10.  Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers.

Authors:  Catherine M Cowan; Shmma Quraishe; Sarah Hands; Megan Sealey; Sumeet Mahajan; Douglas W Allan; Amritpal Mudher
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.